Alexandre Barcia Godoi holds a Bachelor's degree in Pharmacy from the University of Campinas (UNICAMP, 2021) and a Master's degree in Pharmacology with an emphasis on Toxicology and Toxinology from UNICAMP (2024). He is currently pursuing a Ph.D. in Pharmacology at the School of Medical Sciences (UNICAMP), specializing in Toxinology and Toxicology at the Laboratory of Analytical Toxicology of the Campinas Poison Control Center (CIATox - Campinas). Alexandre is also member of the Young Toxicologists Committee (CJTOX) of the Brazilian Society of Toxicology (SBTox) and Young Researcher of the Brazilian League of Epilepsy (LBE). He has experience in Neuroscience, specifically using OMIC approaches (proteomics and metabolomics) and biotechnological tools to study neurodegenerative diseases, as well as in the metabolism of drugs and ADME assays using in vitro and in vivo methods using mass spectrometry (LC-MS and LC-HRMS).
Alexandre Barcia Godoi holds a Bachelor's degree in Pharmacy from the University of Campinas (UNICAMP, 2021) and a Master's degree in Pharmacology with an emphasis on Toxicology and Toxinology from UNICAMP (2024). He is currently pursuing a Ph.D. in Pharmacology at the School of Medical Sciences (UNICAMP), specializing in Toxinology and Toxicology at the Laboratory of Analytical Toxicology of the Campinas Poison Control Center (CIATox - Campinas). Alexandre is also member of the Young Toxicologists Committee (CJTOX) of the Brazilian Society of Toxicology (SBTox) and Young Researcher of the Brazilian League of Epilepsy (LBE). He has experience in Neuroscience, specifically using OMIC approaches (proteomics and metabolomics) and biotechnological tools to study neurodegenerative diseases, as well as in the metabolism of drugs and ADME assays using in vitro and in vivo methods using mass spectrometry (LC-MS and LC-HRMS).